Metastatic Esophageal Squamous Cell Carcinoma

Also known as: Metastatic Oesophageal squamous cell carcinoma / Esophageal Squamous Cell Carcinoma Metastatic / Oesophageal squamous cell carcinoma metastatic / Esophageal squamous cell carcinoma site unspecified stage IV / Oesophageal squamous cell carcinoma site unspecified stage IV / Oesophageal squamous cell carcinoma stage IV / Esophageal squamous cell carcinoma stage IV

DrugDrug NameDrug Description
DB06186IpilimumabA human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma.
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DB14922TislelizumabAn IgG4 variant monoclonal antibody against PD-1 indicated for the treatment of unresectable, locally advanced or metastatic esophageal squamous cell carcinoma
DrugDrug NamePhaseStatusCount
DB11740Adavosertib1Active Not Recruiting1
DB11945Avelumab2Enrolling by Invitation1
DB16680Cadonilimab2Not Yet Recruiting1
DB01101Capecitabine2Recruiting1
DB00515Cisplatin2Not Yet Recruiting1
DB05759Cixutumumab2Active Not Recruiting1
DB12250Cixutumumab2Active Not Recruiting1
DB09035Nivolumab2Recruiting1
DB01229Paclitaxel2Active Not Recruiting1
DB01229Paclitaxel2Not Yet Recruiting1
DB12257Platinum2 / 3Recruiting1
DB15765Sintilimab2 / 3Recruiting1
DB00515Cisplatin3Recruiting1
DB00544Fluorouracil3Recruiting1
DB09078Lenvatinib3Recruiting1
DB00650Leucovorin3Recruiting1
DB11596Levoleucovorin3Recruiting1
DB00526Oxaliplatin3Recruiting1
DB01229Paclitaxel3Recruiting1
DB09037Pembrolizumab3Recruiting1